Sommadossi Jean-Pierre - Insider Non-Derivative Transactions at Atea Pharmaceuticals, Inc. (AVIR) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jan 31, 2025, Sommadossi Jean-Pierre's relationship to Atea Pharmaceuticals, Inc. (AVIR) is Director,Officer (President, CEO, and Chairman), and currently has 389,541 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other AVIR insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Sommadossi Jean-Pierre - Insider Non-Derivative Transactions of AVIR Common Stock

Sommadossi Jean-Pierre - Insider Non-Derivative Transactions at AVIR

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Feb 1, 2025	M -- (Common Stock)	173467	0	290024
Feb 1, 2025	F -- (Common Stock)	88601	3.06	300940
Feb 1, 2025	Acquisition -- (Common Stock)	99517	0	389541
Sep 20, 2024	Sell -- (Common Stock)	1841	4	5866025
Sep 19, 2024	Sell -- (Common Stock)	22187	4.03	5867866
Sep 18, 2024	Sell -- (Common Stock)	33941	4.05	5890053
Jun 6, 2024	Sell -- (Common Stock)	1006	4	5923994
Feb 2, 2024	Sell -- (Common Stock)	56910	3.85	116557
Feb 1, 2024	M -- (Common Stock)	173467	0	173467